|
EEA1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.866500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.586300E-02 |
| Normal-vs-Stage2 |
2.830200E-01 |
| Normal-vs-Stage3 |
4.387600E-01 |
| Normal-vs-Stage4 |
5.295800E-02 |
| Stage1-vs-Stage2 |
8.432200E-01 |
| Stage1-vs-Stage3 |
5.985800E-01 |
| Stage1-vs-Stage4 |
9.300000E-01 |
| Stage2-vs-Stage3 |
8.053000E-01 |
| Stage2-vs-Stage4 |
8.115200E-01 |
| Stage3-vs-Stage4 |
5.842000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.192630E-01 |
| Normal-vs-AfricanAmerican |
1.51300999999826E-05 |
| Normal-vs-Asian |
4.668000E-01 |
| Caucasian-vs-AfricanAmerican |
5.78079999999925E-05 |
| Caucasian-vs-Asian |
3.707000E-01 |
| AfricanAmerican-vs-Asian |
1.464730E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.658100E-02 |
| Normal-vs-Female |
7.194500E-02 |
| Male-vs-Female |
8.958000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.518790E-01 |
| Normal-vs-Age(41-60Yrs) |
1.109570E-01 |
| Normal-vs-Age(61-80Yrs) |
9.090200E-02 |
| Normal-vs-Age(81-100Yrs) |
3.630400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.389000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.763000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.233600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.391000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.031200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.208400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.068000E-01 |
| Normal-vs-Grade 2 |
3.773200E-01 |
| Normal-vs-Grade 3 |
4.983700E-03 |
| Normal-vs-Grade 4 |
6.830300E-02 |
| Grade 1-vs-Grade 2 |
8.933600E-01 |
| Grade 1-vs-Grade 3 |
4.789200E-01 |
| Grade 1-vs-Grade 4 |
6.862800E-01 |
| Grade 2-vs-Grade 3 |
1.371780E-01 |
| Grade 2-vs-Grade 4 |
3.888000E-01 |
| Grade 3-vs-Grade 4 |
6.112600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.264800E-01 |
| Normal-vs-ccB subtype |
6.175000E-01 |
| ccA subtype-vs-ccB subtype |
3.824800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.223600E-01 |
| Normal-vs-N1 |
9.285600E-01 |
| N0-vs-N1 |
6.650800E-01 |
|
|
